Results 81 to 90 of about 19,741 (164)

The Safety, Efficacy, and Feasibility of Fecal Microbiota Transplantation in a Population With Bipolar Disorder During Depressive Episodes: A Pilot Parallel Arm Randomized Controlled Trial: Sécurité, efficacité et faisabilité de la transplantation de microbiote fécal chez une population atteinte de troubles bipolaires, au cours d'épisodes dépressifs : essai pilote contrôlé à répartition aléatoire et à groupes parallèles. [PDF]

Can J Psychiatry
Shekarriz S, Vigod SN, Bianco T, Bala A, Hao C, Allard JP, Hota S, Poutanen S, Surette MG, Taylor VH.   +9 more
europepmc   +1 more source

603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration

Journal for ImmunoTherapy of Cancer, 2020
David Jackson, Shelley Ackerman, David Dornan, Michael Alonso, Felix Hartmann, Cecelia Pearson, Joseph Gonzalez, Po Yi Ho, Samuel Kimmey, Andrew Luo, Benjamin Ackerman, Arthur Lee, Richard Laura, Jason Paik, Karla Henning, Steven Chapin, Bruce Devens, Sean Bendall, Edgar Engleman   +18 more
doaj   +1 more source

Correction: A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer. [PDF]

Front Immunol
Chen L, Wang P, Di Gioia C, Yuan M, Zhang Z, Miao J, Yan W, Zhao G, Jia Y, Wang N, Zhang Z, Guo H, Marelli G, Dunmall LC, Lemoine NR, Wang Y.   +15 more
europepmc   +1 more source

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma. [PDF]

J Clin Oncol
Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson ML, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Oluwole OO, Yakoub-Agha I, Khanal R, Rosenblatt JD, Wulff J, Shen RR, Zhang W, Poddar S, Miao H, Nikolajeva O, Jacobson CA.   +22 more
europepmc   +1 more source

Deciphering the role and contribution of AAV immune responses to DRG toxicity. [PDF]

Mol Ther Adv
Hordeaux J, Chan YK.
europepmc   +1 more source

Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors. [PDF]

Cancer Commun (Lond)
Kluger H, Grigoleit GU, Thomas S, Domingo-Musibay E, Chesney JA, Sanmamed MF, Medina T, Ziemer M, Whitman E, Finckenstein FG, Gastman B, Chou J, Wu X, Sulur G, Fiaz R, Qi R, Sarnaik AA.   +16 more
europepmc   +1 more source

Comparative analysis of NSG and NBSGW mice for preclinical evaluation of gene-modified human hematopoietic stem and progenitor cells. [PDF]

Stem Cell Res Ther
Kuo CY, Harrington S, Campo-Fernandez B, Wyman SK, Wu X, Zhang R, Espinoza A, de Andrade Silva BJ, Sanchez JM, Fitz-Gibbon S, Tseng CH, Pellegrini M, Bonner M, Romero Z.   +13 more
europepmc   +1 more source

Caution in interpreting disease-modification claims with lecanemab: Selective reporting and causal inference. [PDF]

Alzheimers Dement
Schneider LS, Kennedy RE, Cutter G.
europepmc   +1 more source

Evaluation of Plasma Polyethylene Glycol (PEG) Levels in a Healthy Adult Population. [PDF]

Int J Toxicol
Kubesch K, Lubich C, Mascher D, Tangada S, Turecek PL.   +4 more
europepmc   +1 more source

Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemia. [PDF]

Genome Biol
Rathgeber AC, Fernandes SM, Nagler A, Li S, Dorfman DM, Bullinger L, Davids MS, Brown JR, Livak KJ, Ludwig LS, Wu CJ, Penter L.   +11 more
europepmc   +1 more source